GlaxoSmithKline’s decision to change the way it promotes its products and compensates its employees could change the drug business forever.
For this story and more tune in tonight.
Hosts
Top Stories from CNBC- Pelosi believes coronavirus stimulus deal still possible as Democrats prepare new package
- Democrats seek to turn Supreme Court fight into referendum on Obamacare
- Antarctica, the only continent without coronavirus, braces for summer rotation
- Supreme Court confirmation hearings to start in two weeks, Sen. Lindsey Graham says
- Office real estate market will get back to pre-Covid level, in 2025: Cushman & Wakefield
